Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

KS Emerging Markets Healthcare Index ETF (KMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	KMED
Company	KS Emerging Markets Healthcare Index ETF
Price Information
Exchange	NYSE Arca
Open	18.81
High	18.81
Low	18.81
Latest	18.81
Change	-0.53
% Change	-2.72%
Volume	100
20-Day Average Volume	255
Previous Close	19.34
Industry	N/A
Has Options	No
Technicals
20-Day Moving Average	19.29
20-Day Raw Stochastic	29.38%
20-Day Relative Strength	36.38
Weighted Alpha	-12.81
Today's Opinion	100% Sell
Previous Opinion	96% Sell
Last Month's Opinion	88% Sell
Performance
5-Days
%Chg	-3.04% since 10/11/23
Low	18.81 on 10/18/23
High	19.41 on 10/12/23
1-Month
%Chg	-5.64% since 09/18/23
Low	18.50 on 10/03/23
High	19.89 on 09/19/23
3-Month
%Chg	-9.00% since 07/18/23
Low	18.50 on 10/03/23
High	21.42 on 07/28/23
6-Month
%Chg	-14.23% since 04/18/23
Low	18.50 on 10/03/23
High	22.38 on 04/27/23
Key Statistics
Market Capitalization, $K	1,936
Shares Outstanding, K	100
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	0.58
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	N/A
Next Ex-Dividends Date	12/28/22
Ratios
Price/Earnings ttm	N/A